Discontinuation report HELIXATE FS
Report ID | 47645 |
Drug Identification Number | 02243188 |
Brand name | HELIXATE FS |
Common or Proper name | Hemophilic factor |
Company Name | BAYER HEALTHCARE LLC |
Market Status | CANCELLED POST MARKET |
Active Ingredient(s) | ANTIHEMOPHILIC FACTOR |
Strength(s) | 1000UNIT |
Dosage form(s) | POWDER FOR SOLUTION |
Route of administration | INTRAVENOUS |
Packaging size | 2.5 mL |
ATC code | B02BD |
ATC description | VITAMIN K AND OTHER HEMOSTATICS |
Reason for discontinuation | Business reasons |
Anticipated discontinuation date | |
Actual discontinuation date | 2018-04-05 |
Remaining supply date | 2017-03-24 |
Discontinuation status | Discontinued |
Discontinuation decision reversal | No |
Information on remaining supply | |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 100 BAYER BOULEVARD WHIPPANY, NEW JERSEY UNITED STATES 07981 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v1 | 2018-05-01 | English | Compare |
v2 | 2018-05-03 | English | Compare |
v3 | 2018-05-03 | French | Compare |
Showing 1 to 3 of 3